Yasheng (OTC:HERB) Stock, Quote.Headers.trade-ideas

Yasheng Group is a Colorado corporation U.S. company, that conducts business operations in the U.S. , China, Philippine through four segments: Mining, Agriculture. Biotechnology and Blockchain+ IOT. The company's agriculture products include herbal medicine, herbal organic food, ginkgo, songaricum, betel nut, coconut, coffee, wolfberry, hemp, etc. It also designs, develops and markets new technologies related to agriculture and genetic biology.

News

Movers & Shakers

Intraday Update

Markets

Movers

Trading Ideas

General

ABMD

ADPT

AGIO

AKCA

ALKS

ANAB

APEI

APGMF

ASMB

AVGR

AXDDF

BBIO

BIG BLOCKCHAIN INTELGNCE by Big Blockchain Intelligence Group Inc.

BBKCF

BCDA

BIMI

BKFCF

BMRN

BOMN

CALA

CANB

CBDS

CBIO

CCHWF

CDBMF

CEIX

CGNSF

CHCJY

CHFS

CHWY

CLVS

CNBX

CNNXF

CNPOF

CNRD

CNTMF

CPCAF

CRVS

CRWD

CRWOY

CVSI

CXXIF

DTST

DYMEF

DZSI

EAWD

EEIG

ELGX

EMERALD HEALTH THERAPUTCS by Emerald Health Therapeutics Inc.

EMHTF

ENOB

ENRFF

EOPT

EPAY

EVTI

EUROPEAN ELECTRIC METALS by European Electric Metals Inc.

EVXXF

EWLL

EZPW

FFXXF

FLDM

FPRX

FTSI

FUAPF

FULC

FUNN

FVANF

GLDFF

GNAL

GNFTF

GNLN

HABC

HEGIF

HERB

HLUYY

HSDT

HSSHF

IBSS

INCAF

INPX

INQD

IRNC

ITCI

IZEA

JAPSY

JUGGERNAUT EXPL LTD by Juggernaut Expl. Ltd.

JUGRF

KALYTERA THERAPEUTICS ORD by Kalytera Therapeutics Inc.

KALTF

KALV

KERN

KLXE

KSHB

LEAI

LFCOF

LPTX

LTMCF

LVVV

Stocks That Hit 52-Week Lows On Monday

Yasheng Group

Herbal Dispatch Inc

HERBAL DISPATCH INC by HERBAL DISPATCH INC.

Herbalife Ltd

HERBORIUM GROUP INC by Herborium Group, Inc.

Herborium Group Inc

Canadian medical cannabis giant Aurora Cannabis Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) (TSX:<a class="ticker" href="https://www.benzinga.com/stock/ACB#TSX">ACB</a>) announced on Friday the appointments of CEO Miguel Martin to the additional role of executive chairman and outgoing chairman Ron Funk as lead independent director.
Both are backed by unanimous votes by the company's board of director and are effective immediately.
Martin has led Aurora as CEO and a director since 2020, driving the company&#8217;s financial recovery and successful business transformation.
Why It Matters: The board said combining the CEO and chairman roles will "promote strong and consistent leadership, directional clarity, and effective and efficient decision making — all of which better position Aurora to execute on its vision for global leadership."
&#8220;I am excited to take on this expanded role and equally thrilled that we will have the ongoing benefit of Ron&#8217;s extensive business experience, deep institutional knowledge and meticulous Board leadership and governance expertise as Lead Independent Director,&#8221; Martin said.
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40512437/aurora-cannabis-dominates-30-of-canadas-medical-marijuana-exports-will-its-bold-int">Aurora Cannabis Dominates 30% Of Canada&#8217;s Medical Marijuana Exports: Will Its Bold International Expansion Pay Off?</a>
What's Next: Martin's expanded role allows him to lead in setting the board agenda. As lead independent director, Funk will continue to focus on ensuring the board functions effectively and independently of the company&#8217;s management.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/cannabis-conference/"><img loading="lazy" decoding="async" width="970" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20093254/ccc-oct-24-banner__1_-31.gif" alt="" class="wp-image-558446" /></a></figure>
<h1 class="wp-block-heading">Changes To Board Committee Compositions And Recent Moves</h1>
Michael Singer, who previously acted as executive chairman and interim CEO, was appointed to the Audit Committee and the Human Resource and Compensation Committee. Rajesh Uttamchandani was appointed to the HRCC and the Nominating and Corporate Governance Committee.
In the meantime, the company was working on innovating its operations via research in auto-flowering technology. Aurora received a U.S. Patent 12,002,546, "Methods of Determining Sensitivity to Photoperiod in Cannabis," allowing for its breeding program to identify and select for the auto-flowering trait.
The company said on Tuesday the innovative work provides foundational insight into the flowering mechanism in cannabis. The research would support future breeding strategies. It also could be utilized to advance outdoor cannabis cultivation in high-latitude regions, such as Canada.
ACG Price Action: Aurora's shares traded 0.87% lower at $5.72 per share Friday morning at publication.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/09/40783070/auroras-cbd-lozenge-partnership-heres-where-to-find-the-new-product">Aurora&#8217;s CBD Lozenge Partnership: Here&#8217;s Where To Find The New Product</a></li>
</ul>

Cannabis

Entrepreneurship

Management

TSX:ACB

Aurora Cannabis CEO Takes On Dual Role: Here's What's Behind The Leadership Change

Europe&rsquo;s biggest automaker, Volkswagen (OTC: <a class="ticker" href="https://www.benzinga.com/stock/vwagy#OTC">VWAGY</a>) is considering plant closures for the first time in its 87-year-old history. But Volkswagen is merely a reflection of a struggling European auto industry that is currently challenged on many fronts, with its struggles being both the global competition and its declining appeal.&nbsp;
Europe&rsquo;s automotive industry is struggling with many issues simultaneously.&nbsp;
According to&nbsp;Bloomberg Intelligence, one in three European factories of carmaking behemoths, namely Volkswagen, Bayerische Motoren Werke Aktiengesellschaft (OTC: <a class="ticker" href="https://www.benzinga.com/stock/bmwyy#OTC">BMWYY</a>), Mercedes-Benz Group AG (OTC: <a class="ticker" href="https://www.benzinga.com/stock/mbgaf#OTC">MBGAF</a>)(OTC: <a class="ticker" href="https://www.benzinga.com/stock/mbgyy#OTC">MBGYY</a>), Stellantis N.V. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/stla#NYSE">STLA</a>) and Renault (OTC: <a class="ticker" href="https://www.benzinga.com/stock/rnlsy#OTC">RNLSY</a>) is underutilized.&nbsp;Meanwhile, Chinese automakers such as BYD (OTC: <a class="ticker" href="https://www.benzinga.com/stock/byddy#OTC">BYDDY</a>) are off to conquer Europe. To avoid tarrifs on China-made EVs, they are planning to make their own factories on the European continent.&nbsp;
Volkswagen is only one of the first victims.
Volkswagen Group CEO Oliver Blume&nbsp;openly spoke of the serious situation that Europe&rsquo;s automotive industry is facing with Germany in particular falling from grace as a competitive manufacturing location. Volkswagen has also falen from grace in China, its single biggest market. During the first half of 2024, Volkswagen&rsquo;s deliveries in China dropped 7%&nbsp;YoY with group operating profit tumbling 11.4%&nbsp;to $11.2 billion. Volkswagen is losing out to local brands in China like BYD and those brands are now going for its home market.&nbsp;&nbsp;
Stellantis has also been hit by slowing demand in Europe.
In Italy, Stellantis is hitting the brakes. In response to the sales crisis, Stellantis halted production of its electric Fiat 500e for a month at its Mirafiori facility that is located near Turin. Stellantis also revealed that the site will be undergoing a significant transformation that will involve an investment worth&nbsp;&euro;100 million. Stellantis is expected to start making a hybrid version of the Fiat 500&nbsp;sometimes next year.&nbsp;
In addition to its European struggles, Stellantis is also facing a shrinking share in North America. During the first half of 2024, net revenues dropped 14% YoY while net profit took a 48% YoY plunge.
With Chinese EV makers navigating new roads, determined to conquer the world, simple cost-cutting measures won&rsquo;t do.&nbsp;
European automakers are having a hard time keeping up with Chinese EV makers. The increased tariffs that the EU imposed on Chinese EV makers led to significant backlash and concerns that this will make it more difficult for the EU to achieve its net-zero goals as Chinese EVs are more popular with consumers, both due to their more favorable pricing and greater features. Moreover, tarrifs are seen as&nbsp;a minor speed bump for an EV powerhouse like BYD.&nbsp;Regardless of their legacy, European automakers who fail to adapt quickly enough will be left on the sidelines as Chinese EV makers like BYD threaten to leave them in the dust.
DISCLAIMER: This content is for informational purposes only. It is not intended as investing advice.
This article is from an unpaid external contributor. It does not represent Benzinga's reporting and has not been edited for content or accuracy.

BMWYY

BYDDY

MERCEDES BENZ GROUP AG by Mercedes Benz Group AG

MBGAF

MERCEDES-BENZ UNSP / ADR by Mercedes Benz Group AG

MBGYY

RNLSY

STLA

VWAGY

Volkswagen's Crisis Is The Reflection Of Europe's Automotive Struggles

Cantor Fitzgerald analyst Louise Chen reiterates Oncolytics Biotech (TSX:<a class="ticker" href="https://www.benzinga.com/stock/ONC#TSX">ONC</a>) with a Overweight.

Reiteration

Analyst Ratings

TSX:ONC

Cantor Fitzgerald Reiterates Overweight on Oncolytics Biotech

Piper Sandler analyst Ryan Todd maintains Phillips 66 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>) with a Overweight and lowers the price target from $151 to $136.

Price Target

Piper Sandler Maintains Overweight on Phillips 66, Lowers Price Target to $136

UBS analyst Ross Fowler maintains Xcel Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XEL#NASDAQ">XEL</a>) with a Neutral and raises the price target from $66 to $67.

UBS Maintains Neutral on Xcel Energy, Raises Price Target to $67

UBS analyst Daniel Ford maintains Southern (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SO#NYSE">SO</a>) with a Neutral and raises the price target from $90 to $91.

UBS Maintains Neutral on Southern, Raises Price Target to $91

Cantor Fitzgerald analyst Louise Chen reiterates Novo Nordisk (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) with a Overweight and maintains $160 price target.

Cantor Fitzgerald Reiterates Overweight on Novo Nordisk, Maintains $160 Price Target

A year after Meta Platforms introduced its artificial intelligence assistant, a picture is emerging of how people are using it—and how that differs from usage of OpenAI's ChatGPT, the leading conversational AI. Most people who use Meta AI daily do so through WhatsApp, according to a person who has seen recent internal data; the second biggest group arrives from Facebook. Few Instagram users are tapping Meta AI. Among monthly users, Facebook has a slight edge over WhatsApp, the person said.
<a href="https://www.theinformation.com/articles/whatsapp-dominates-meta-ai-use" title="https://www.theinformation.com/articles/whatsapp-dominates-meta-ai-use">https://www.theinformation.com/articles/whatsapp-dominates-meta-ai-use</a>

'WhatsApp Dominates Meta AI Use' - The Information

GameStop Corp&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) stock price is up 17.04% year-to-date but down 12.43% over the past month.
The Federal Trade Commission (FTC) recently slapped a fine on CEO Ryan Cohen, adding fuel to the fire, and further stoking the volatility that GameStop stock investors are used to.
Cohen agreed to <a href="https://www.benzinga.com/news/large-cap/24/09/40938804/gamestop-ceo-ryan-cohen-penalized-nearly-1m-over-wells-fargo-share-acquisition">pay almost $1 million</a> to settle charges from the FTC. His failure to report the acquisition of Wells Fargo shares promptly resulted in a sharp focus on his management.
This legal hiccup hasn't exactly helped GameStop&#8217;s stock price, and it's left investors wondering whether this meme stock has run out of extra lives.
<h2 class="wp-block-heading">GameStop Stock Chart Bearish: More &#8216;Game Over&#8217; Than &#8216;Level Up&#8217;? </h2>
GameStop stock's technical indicators are signaling a potential storm.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent092024&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="631" height="458" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20085322/Screenshot-2024-09-20-at-6.22.51-PM.png" alt="" class="wp-image-558320" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20085322/Screenshot-2024-09-20-at-6.22.51-PM.png 631w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20085322/Screenshot-2024-09-20-at-6.22.51-PM-300x218.png 300w" sizes="(max-width: 631px) 100vw, 631px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent092024&amp;t=be2bearmibe3na1">Chart created using Benzinga Pro</a>
The stock's price sits at $19.51, well below critical moving averages:
<ul>
<li>Eight-day SMA: $20.57</li>
<li>20-day SMA: $21.58</li>
<li>50-day SMA: $22.74</li>
</ul>
With the stock trading below these moving averages, it's clear that GameStop is under intense selling pressure. The 200-day SMA is also closing in and if the trend continues the stock may drop below this average, signaling long-term bearishness.
Read Also: <a href="https://www.benzinga.com/markets/equities/24/09/40826056/jim-cramer-agrees-gamestop-should-consider-operating-as-a-bank-and-labels-the-meme-stock-as-mass">Jim Cramer Agrees GameStop Should Consider Operating As A Bank And Labels The Meme Stock As &#8216;Massively Overvalued&#8217; SPAC</a>
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent092024&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="631" height="458" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20085559/Screenshot-2024-09-20-at-6.25.47-PM.png" alt="" class="wp-image-558330" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20085559/Screenshot-2024-09-20-at-6.25.47-PM.png 631w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20085559/Screenshot-2024-09-20-at-6.25.47-PM-300x218.png 300w" sizes="(max-width: 631px) 100vw, 631px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent092024&amp;t=be2bearmibe3na1">Chart created using Benzinga Pro</a>
The MACD (Moving Average Convergence Divergence) sits at a negative 0.78, confirming a bearish signal.
The Relative Strength Index (RSI) for GameStop stock is 37.89 and declining gradually, putting it in very close to the oversold territory. This could be a ray of hope for traders expecting a bounce back.
However, the stock is still struggling to break through any key resistance levels. This indicates further downside risks.
The Bollinger Bands (25) show a range of $18.81 &#8211; $24.47, with GameStop stock trading at $19.51, suggesting that the stock is sitting at the lower end of its range. The risk of it breaking lower increases unless some bullish catalyst intervenes.
<h2 class="wp-block-heading">Roaring Kitty Returns: A Meme Stock Spark? </h2>
Interestingly, meme stock hero Keith Gill, a.k.a. Roaring Kitty, recently resurfaced on social media, and GameStock stock&#8217;s price saw a small uptick in response.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://t.co/9xPMBKesNV">pic.twitter.com/9xPMBKesNV</a>
&mdash; Roaring Kitty (@TheRoaringKitty) <a href="https://twitter.com/TheRoaringKitty/status/1832086356849250635?ref_src=twsrc%5Etfw">September 6, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
However, these short-lived bumps are becoming less impactful as GameStop stock investors look for more sustainable growth rather than internet-driven hype.
GameStop may be oversold, but the bearish technical indicators outweigh any meme stock optimism. Unless a significant fundamental shift occurs, the stock seems poised for further declines. 
For now, GameStop stock bulls might have to wait until the next big catalyst.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40946963/bitcoin-worth-63-000-pulled-in-33-pack-of-trading-cards-at-gamestop-mind-boggling-story-go">Bitcoin Worth $63,000 Pulled In $33 Pack Of Trading Cards At GameStop &#8211; &#8216;Mind-Boggling&#8217; Story Goes Viral, Highlights Crypto Redemption Card</a></li>
</ul>
Image: Shutterstock

Gaming

Technicals

Tech

GameStop Stock Stuck In Level-Up Limbo: Can It Shake Off The Bearish Trend?

UBS analyst Julien Dumoulin-Smith maintains Alliant Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNT#NASDAQ">LNT</a>) with a Neutral and raises the price target from $64 to $65.

UBS Maintains Neutral on Alliant Energy, Raises Price Target to $65

In the last three months, 17 analysts have published ratings on Builders FirstSource (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLDR#NYSE">BLDR</a>), offering a diverse range of perspectives from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">9</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $197.53, along with a high estimate of $230.00 and a low estimate of $175.00. Experiencing a 0.94% decline, the current average is now lower than the previous average price target of $199.41. 
<img src="https://www.benzinga.com/files/images/story/2024/1726840947_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of Builders FirstSource among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jeffrey Stevenson</td>
<td>Loop Capital</td>
<td>Raises</td>
<td>Buy</td>
<td>$230.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Rafe Jasrosich</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$198.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Tyler Batory</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$225.00</td>
<td>$205.00</td>
</tr>
<tr>
<td>Keith Hughes</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$220.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Tyler Batory</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$205.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Collin Verron</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$185.00</td>
<td>$205.00</td>
</tr>
<tr>
<td>Stanley Elliott</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$195.00</td>
<td>$217.00</td>
</tr>
<tr>
<td>Tyler Batory</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$190.00</td>
<td>$230.00</td>
</tr>
<tr>
<td>Reuben Garner</td>
<td>Benchmark</td>
<td>Lowers</td>
<td>Buy</td>
<td>$200.00</td>
<td>$220.00</td>
</tr>
<tr>
<td>Matthew Bouley</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$182.00</td>
<td>$188.00</td>
</tr>
<tr>
<td>Alex Rygiel</td>
<td>B. Riley Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$187.00</td>
<td>$197.00</td>
</tr>
<tr>
<td>Mike Dahl</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$178.00</td>
<td>$193.00</td>
</tr>
<tr>
<td>David Manthey</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$190.00</td>
<td>$185.00</td>
</tr>
<tr>
<td>Rafe Jasrosich</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$180.00</td>
<td>$183.00</td>
</tr>
<tr>
<td>Tyler Batory</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$230.00</td>
<td>$242.00</td>
</tr>
<tr>
<td>Matthew Bouley</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$188.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Jay McCanless</td>
<td>Wedbush</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$175.00</td>
<td>$215.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Builders FirstSource. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Builders FirstSource compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Builders FirstSource's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/BLDR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Builders FirstSource analyst ratings.</a>
<h2>All You Need to Know About Builders FirstSource</h2>
Builders FirstSource Inc is a manufacturer and supplier of building materials. The company offers structural and related building products such as factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The products can be designed for each home individually and are installed by Builders FirstSource. The company's construction-related services include professional installation, turn-key framing, and shell construction. Builders FirstSource's customers range from large production builders to small custom homebuilders.
<h3>Builders FirstSource: A Financial Overview</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: Builders FirstSource's revenue growth over a period of 3 months has faced challenges. As of 30 June, 2024, the company experienced a revenue decline of approximately -1.6%. This indicates a decrease in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: Builders FirstSource's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 7.72%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Builders FirstSource's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 7.43%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Builders FirstSource's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 3.14%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Builders FirstSource's debt-to-equity ratio is below the industry average. With a ratio of 1.01, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BLDR

17 Analysts Assess Builders FirstSource: What You Need To Know

Throughout the last three months, 11 analysts have evaluated Valero Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLO#NYSE">VLO</a>), offering a diverse set of opinions from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $161.27, a high estimate of $175.00, and a low estimate of $123.00. Observing a downward trend, the current average is 3.85% lower than the prior average price target of $167.73. 
<img src="https://www.benzinga.com/files/images/story/2024/1726840909_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
A clear picture of Valero Energy's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ryan Todd</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$123.00</td>
<td>$169.00</td>
</tr>
<tr>
<td>Neil Mehta</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Sell</td>
<td>$131.00</td>
<td>$149.00</td>
</tr>
<tr>
<td>Nitin Kumar</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$171.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$172.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$165.00</td>
<td>$156.00</td>
</tr>
<tr>
<td>Nitin Kumar</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$175.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Paul Cheng</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Outperform</td>
<td>$173.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$156.00</td>
<td>$179.00</td>
</tr>
<tr>
<td>Theresa Chen</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$165.00</td>
<td>$171.00</td>
</tr>
<tr>
<td>John Royall</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$172.00</td>
<td>$178.00</td>
</tr>
<tr>
<td>Theresa Chen</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$171.00</td>
<td>$173.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Valero Energy. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Valero Energy compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Valero Energy's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Valero Energy's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/VLO/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Valero Energy analyst ratings.</a>
<h2>Discovering Valero Energy: A Closer Look</h2>
Valero Energy is one of the largest independent refiners in the United States. It operates 15 refineries, with a total throughput capacity of 3.2 million barrels a day in the US, Canada, and the United Kingdom. Valero also owns 12 ethanol plants with capacity of 1.6 billion gallons a year and holds a 50% stake in Diamond Green Diesel, which has the capacity to produce 1.2 billion gallons per year of renewable diesel.
<h3>Breaking Down Valero Energy's Financial Performance</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Decline in Revenue: Over the 3 months period, Valero Energy faced challenges, resulting in a decline of approximately -0.06% in revenue growth as of 30 June, 2024. This signifies a reduction in the company's top-line earnings. When compared to others in the Energy sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Valero Energy's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.54% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 3.41%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Valero Energy's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.39% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Valero Energy's debt-to-equity ratio is below the industry average. With a ratio of 0.42, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Ratings For Valero Energy

UBS analyst Alex Kramm maintains FactSet Research Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) with a Neutral and raises the price target from $455 to $485.

UBS Maintains Neutral on FactSet Research Systems, Raises Price Target to $485

Providing a diverse range of perspectives from bullish to bearish, 11 analysts have published ratings on MercadoLibre (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>) in the last three months.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated MercadoLibre and provided 12-month price targets. The average target is $2330.45, accompanied by a high estimate of $2530.00 and a low estimate of $2025.00. This current average reflects an increase of 11.16% from the previous average price target of $2096.50. 
<img src="https://www.benzinga.com/files/images/story/2024/1726840882_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
A clear picture of MercadoLibre's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrew Ruben</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$2500.00</td>
<td>$2175.00</td>
</tr>
<tr>
<td>Robert Ford</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$2500.00</td>
<td>$2250.00</td>
</tr>
<tr>
<td>Deepak Mathivanan</td>
<td>Cantor Fitzgerald</td>
<td>Announces</td>
<td>Overweight</td>
<td>$2530.00</td>
<td>-</td>
</tr>
<tr>
<td>James Friedman</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Positive</td>
<td>$2350.00</td>
<td>$2300.00</td>
</tr>
<tr>
<td>Marvin Fong</td>
<td>BTIG</td>
<td>Raises</td>
<td>Buy</td>
<td>$2250.00</td>
<td>$2025.00</td>
</tr>
<tr>
<td>James Friedman</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Positive</td>
<td>$2300.00</td>
<td>$2000.00</td>
</tr>
<tr>
<td>Tobias Stingelin</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$2200.00</td>
<td>$2000.00</td>
</tr>
<tr>
<td>Irma Sgarz</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$2480.00</td>
<td>$2180.00</td>
</tr>
<tr>
<td>Marcelo Santos</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$2400.00</td>
<td>$2150.00</td>
</tr>
<tr>
<td>Trevor Young</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$2100.00</td>
<td>$2000.00</td>
</tr>
<tr>
<td>Marvin Fong</td>
<td>BTIG</td>
<td>Raises</td>
<td>Buy</td>
<td>$2025.00</td>
<td>$1885.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to MercadoLibre. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of MercadoLibre compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into MercadoLibre's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/MELI/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on MercadoLibre analyst ratings.</a>
<h2>About MercadoLibre</h2>
MercadoLibre runs the largest e-commerce marketplace in Latin America, with more than 218 million active users and 1 million active sellers across 18 countries stitching into its commerce network or fintech solutions as of the end of 2023. The company operates a host of complementary businesses to its core online shop, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago and Mercado Credito), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.
<h3>MercadoLibre: A Financial Overview</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Over the 3 months period, MercadoLibre showcased positive performance, achieving a revenue growth rate of 41.51% as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Discretionary sector.
Net Margin: MercadoLibre's net margin excels beyond industry benchmarks, reaching 10.47%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): MercadoLibre's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 15.07% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): MercadoLibre's ROA stands out, surpassing industry averages. With an impressive ROA of 2.72%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a below-average debt-to-equity ratio of 1.48, MercadoLibre adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Basics of Analyst Ratings</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MELI

Assessing MercadoLibre: Insights From 11 Financial Analysts

By <a href="https://elplanteo.com/author/lucia-tedesco/" target="_blank" rel="noreferrer noopener">Natalia Kesselman</a> via <a href="https://elplanteo.com/uruguay-cannabis-medicinal-pharmin-remate/" target="_blank" rel="noreferrer noopener">El Planteo</a>
A medicinal cannabis production facility in <a href="https://elplanteo.com/noticias/latinoamerica/uruguay/">Uruguay</a> was auctioned off for just $335,000 &#8212; roughly the price of a two-bedroom apartment in the South American country, or the price of a studio apartment in the U.S. This figure has sparked considerable controversy, especially given that the company's original valuation stood at $9.5 million.
The facility belonged to Pharmin, a company backed by Georgian capital focused on the production and export of high-quality medicinal cannabis to Europe and Asia. Despite its promising prospects, the company vanished suddenly from the market in 2024. The whereabouts of its owners remain a mystery.
<h2 class="wp-block-heading">Layoffs Without Severance And Owners Nowhere To Be Found</h2>
Pharmin was founded in 2019 and quickly became a notable player in the Latin American <a href="https://elplanteo.com/cannabis-medicinal/">medicinal cannabis</a> industry. With a 2.3-hectare (5.68-acre) property in Uruguay, the company had the capacity to produce one ton of dried flower per month. However, in the early months of 2024, Pharmin abruptly shut down, laying off 65 workers via WhatsApp messages. To make matters worse, not only were they denied severance pay, but they also weren't deregistered from the Social Security Bank (BPS).
See also: <a href="https://www.benzinga.com/markets/cannabis/24/09/40926566/argentinas-cannabis-industry-shakeup-will-the-new-government-appointed-comptroller-boost-busines">Argentina&#8217;s Cannabis Industry Shakeup: Will The New Government-Appointed Comptroller Boost Business Opportunities?</a>
The Ministry of Labor and Social Security (MTSS) has attempted to locate the company's responsible parties, but so far, their efforts have been unsuccessful. The only local contact, Nicolás Bustillo, brother of Uruguay's former foreign minister, has also cut communication with authorities.
<h2 class="wp-block-heading">The Auction Of Pharmin's Medicinal Cannabis Production Facility</h2>
Earlier this month, by court order due to the absence of the owners, Pharmin&#8217;s facilities were auctioned off. The sale was divided into two large lots. The first, a 24,000-square-meter greenhouse equipped with the latest technology, was sold for $205,000. According to Infobae, the buyer, a horticultural producer from Paysandú, is involved in both agriculture and drone-assisted forestry. The second lot, which included a fully equipped laboratory, was sold for $130,000 to a representative from Zonamérica, the business park where the facility was located.
"A 24,000-square-meter <a href="https://elplanteo.com/app-vpd-cultivo-interior-dr-greenhouse/">greenhouse</a>, fully roofed with polycarbonate and lighting, was auctioned. There are approximately 18 sections with lights, and each section has 240 lights. Each light costs $1,000," explained Germán González, a leader of the Union of Rural and Agro-Industrial Workers of Uruguay (UTRAU), who described the total amount raised as "laughable."
"You need to understand what you&#8217;re selling. You can't give away something that cost $9.5 million for just $200,000. You can't even cover the cost of the nylon," he added indignantly.
González also criticized the speed of the auction, arguing that there wasn't enough time for other interested parties, including the workers, to participate. "We didn't have time to enter the auction. This didn't support the productive unit. They didn't wait for a trustee to be appointed," he remarked. "It wasn't handled correctly."
During the auction, González witnessed the process and lamented that no solution was offered to benefit the employees. "No one defended the workers. I was at the auction, and the auctioneer did his job, taking a long time to see if anyone would make a better offer. But when the final offer came, he looked at the bailiff, and the bailiff gave the go-ahead for the $205,000," he recalled.
This auction is not an isolated incident. González mentioned another company, Boreal, linked to the businessman who was murdered in Punta del Este by his ex-partner, which also went to auction. However, no agreement was reached as the base price was too low.
The fate of Pharmin, its sudden disappearance and the sale of its assets at prices far below their original value reveal the ongoing tensions faced by both affected workers and the medicinal cannabis business sector in Uruguay. Legal and financial uncertainty lingers, with no clear resolution in sight for those involved in this controversial case.
This article is from an external unpaid contributor. It does not represent Benzinga&#8217;s reporting and has not been edited for content or accuracy.

Latin America

Multi-Million Dollar Cannabis Facility Auctioned For The Price Of A Studio Apartment: What's Going On In Uruguay?

Ratings for Delek US Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DK#NYSE">DK</a>) were provided by 9 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $22.22, a high estimate of $26.00, and a low estimate of $18.00. Observing a downward trend, the current average is 7.42% lower than the prior average price target of $24.00. 
<img src="https://www.benzinga.com/files/images/story/2024/1726840871_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Delek US Hldgs. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ryan Todd</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$19.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Connor Lynagh</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$22.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Nitin Kumar</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$26.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>John Royall</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$26.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Underweight</td>
<td>$21.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Jason Gabelman</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Sell</td>
<td>$18.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$20.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Paul Cheng</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$25.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>John Royall</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$23.00</td>
<td>$25.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Delek US Hldgs. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Delek US Hldgs compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Delek US Hldgs's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/DK/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Delek US Hldgs analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Discovering Delek US Hldgs: A Closer Look</h2>
Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. Delek's logistics segment sells portions of the petroleum products its refineries produce. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.
<h3>Breaking Down Delek US Hldgs's Financial Performance</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Negative Revenue Trend: Examining Delek US Hldgs's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately -18.45% in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Energy sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of -1.09%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Delek US Hldgs's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -4.48%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Delek US Hldgs's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -0.53%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: With a high debt-to-equity ratio of 3.24, Delek US Hldgs faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>The Significance of Analyst Ratings Explained</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What 9 Analyst Ratings Have To Say About Delek US Hldgs

Across the recent three months, 5 analysts have shared their insights on Coeur Mining (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CDE#NYSE">CDE</a>), expressing a variety of opinions spanning from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $6.9, a high estimate of $8.00, and a low estimate of $5.75. This upward trend is evident, with the current average reflecting a 11.29% increase from the previous average price target of $6.20.
<img src="https://www.benzinga.com/files/images/story/2024/1726840863_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The standing of Coeur Mining among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brian MacArthur</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$7.00</td>
<td>$6.25</td>
</tr>
<tr>
<td>Brian MacArthur</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$6.25</td>
<td>$5.75</td>
</tr>
<tr>
<td>Joe Reagor</td>
<td>Roth MKM</td>
<td>Raises</td>
<td>Buy</td>
<td>$8.00</td>
<td>$7.25</td>
</tr>
<tr>
<td>Brian MacArthur</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$5.75</td>
<td>$5.00</td>
</tr>
<tr>
<td>Kevin O'Halloran</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$7.50</td>
<td>$6.75</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Coeur Mining. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Coeur Mining compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Coeur Mining's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Capture valuable insights into Coeur Mining's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CDE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Coeur Mining analyst ratings.</a>
<h2>All You Need to Know About Coeur Mining</h2>
Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada Mexico, and North America.
<h3>Financial Milestones: Coeur Mining's Journey</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Coeur Mining displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 25.27%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Materials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 0.64%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Coeur Mining's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 0.14%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Coeur Mining's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.07%, the company may face hurdles in achieving optimal financial performance.
Debt Management: With a high debt-to-equity ratio of 0.62, Coeur Mining faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Analyst Ratings: Simplified</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Outlook: Coeur Mining Through The Eyes Of 5 Analysts

Providing a diverse range of perspectives from bullish to bearish, 10 analysts have published ratings on Arcadium Lithium (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALTM#NYSE">ALTM</a>) in the last three months.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Arcadium Lithium, presenting an average target of $4.6, a high estimate of $9.00, and a low estimate of $3.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 21.37%. 
<img src="https://www.benzinga.com/files/images/story/2024/1726840833_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
A comprehensive examination of how financial experts perceive Arcadium Lithium is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kaan Peker</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$3.10</td>
<td>$3.10</td>
</tr>
<tr>
<td>Kaan Peker</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$3.60</td>
<td>$3.60</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Announces</td>
<td>Neutral</td>
<td>$3.00</td>
<td>-</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$3.25</td>
<td>$3.75</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$8.00</td>
<td>$9.00</td>
</tr>
<tr>
<td>Ben Isaacson</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$4.00</td>
<td>$5.50</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$9.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Hugo Nicolaci</td>
<td>Goldman Sachs</td>
<td>Announces</td>
<td>Neutral</td>
<td>$4.30</td>
<td>-</td>
</tr>
<tr>
<td>Kaan Peker</td>
<td>RBC Capital</td>
<td>Announces</td>
<td>Outperform</td>
<td>$4.00</td>
<td>-</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$3.75</td>
<td>$5.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Arcadium Lithium. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Arcadium Lithium compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Arcadium Lithium's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Arcadium Lithium's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ALTM/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Arcadium Lithium analyst ratings.</a>
<h2>Delving into Arcadium Lithium's Background</h2>
Arcadium Lithium is a pure-play lithium producer that was formed in the Allkem-Livent merger in January 2024. Arcadium should benefit from increased lithium demand via higher electric vehicle adoption, as lithium is a key component of EV batteries. The company's low-cost lithium carbonate production comes from two brine resources in Argentina. Arcadium also produces spodumene, a hard rock lithium upstream concentrate, from a mine in Australia and operates downstream lithium hydroxide conversion plants in the United States and China.
<h3>Arcadium Lithium's Financial Performance</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Arcadium Lithium displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 7.93%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 33.67%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 1.38%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Arcadium Lithium's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.87%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Arcadium Lithium's debt-to-equity ratio is below the industry average. With a ratio of 0.11, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Analyst Ratings: What Are They?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALTM

The Latest Analyst Ratings For Arcadium Lithium

Vistra (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>) has outperformed the market over the past 5 years by 16.09% on an annualized basis producing an average annual return of 30.01%. Currently, Vistra has a market capitalization of $34.44 billion. 
Buying $100 In VST: If an investor had bought $100 of VST stock 5 years ago, it would be worth $371.70 today based on a price of $100.25 for VST at the time of writing.
<h3>Vistra's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726840826_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 5 Years Ago Would Be Worth $400 Today

MicroStrategy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) has outperformed the market over the past 15 years by 10.3% on an annualized basis producing an average annual return of 22.12%. Currently, MicroStrategy has a market capitalization of $29.12 billion. 
Buying $1000 In MSTR: If an investor had bought $1000 of MSTR stock 15 years ago, it would be worth $20,116.49 today based on a price of $143.71 for MSTR at the time of writing.
<h3>MicroStrategy's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726840821_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MSTR

Here's How Much $1000 Invested In MicroStrategy 15 Years Ago Would Be Worth Today

YaSheng Group (HERB) has released an update. On February 2, 2024, the Yasheng Group appointed Manny Pacquiao as Chairman of the Board of Directors ...

YaSheng Group Names Manny Pacquiao as New Chairman

Press Releases

Kronos Advanced Technologies Inc. and Yasheng Group Announce Strategic Collaboration to Develop Revolutionary Nuclear Battery.

KNOS

Yasheng

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Yasheng

Yasheng (HERB) Forecast

Yasheng (OTC:HERB) Stock, Quote.Headers.trade-ideas